share_log

Recursion Pharmaceuticals | DEFA14A: Others

SEC announcement ·  Apr 23 17:21
Summary by Moomoo AI
Recursion Pharmaceuticals, Inc., a company listed in the United States, has filed definitive additional materials with the Securities and Exchange Commission (SEC) as part of its proxy statement. This filing, pursuant to Section 14(a) of the Securities Exchange Act of 1934, indicates that the materials are intended for further communication with the company's shareholders in relation to the proxy statement. The company has confirmed that no filing fee is required for this submission. The exact nature of the additional materials was not specified in the announcement.
Recursion Pharmaceuticals, Inc., a company listed in the United States, has filed definitive additional materials with the Securities and Exchange Commission (SEC) as part of its proxy statement. This filing, pursuant to Section 14(a) of the Securities Exchange Act of 1934, indicates that the materials are intended for further communication with the company's shareholders in relation to the proxy statement. The company has confirmed that no filing fee is required for this submission. The exact nature of the additional materials was not specified in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more